The Fly

1Life dips after WSJ says FTC considering antitrust suit against Amazon

Shares of 1Life Healthcare (ONEM) are down 41c or about 3%, to $15.21 in morning trading after The Wall Street Journal’s Dana Mattioli and Brent Kendall reported, citing sources, that The Federal Trade Commission is considering challenges to an array of practices by Amazon (AMZN) that it considers anticompetitive. Which aspects of Amazon’s business the FTC would target in a potential Amazon lawsuit couldn’t be learned, the report said. Amazon has entered into an agreement to acquire 1Life, which operates a membership-based primary care platform under the One Medical brand.

Published first on TheFly

See Insiders’ Hot Stocks on TipRanks >>

Read More on ONEM:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More